Search research articles
Contact Us
Filters
Showing results (661-670 of 674) with videos related to
Page
of 68
Sort By:
Disease Models & Mechanisms
|
October 11, 2019
Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice
Claudia Figueroa-Romero, Kai Guo, Benjamin J Murdock, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 14, 2018
OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9
Takenobu Ishii, Montserrat Ruiz-Torruella, Atsushi Ikeda, et al.
Clinical Endocrinology
|
December 20, 2021
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society
Julie A Miller, Justin Gundara, Simon Harper, et al.
Clinical Endocrinology
|
December 21, 2021
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society
Frances Milat, Sabashini K Ramchand, Madhuni Herath, et al.
European Urology Oncology
|
January 28, 2024
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)
Lih-Ming Wong, Tom Sutherland, Elisa Perry, et al.
Lancet (London, England)
|
March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.
European Urology Oncology
|
November 29, 2024
Baseline Nodal Status on <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
Michael S Hofman, Veeru Kasivisvanathan, Emma Link, et al.
Physical Review Letters
|
March 29, 2020
Extended Search for the Invisible Axion with the Axion Dark Matter Experiment
T Braine, R Cervantes, N Crisosto, et al.
Physical Review Letters
|
April 7, 2025
ADMX Axion Dark Matter Bounds around 3.3 μeV with Dine-Fischler-Srednicki-Zhitnitsky Discovery Ability
C Goodman, M Guzzetti, C Hanretty, et al.
Physical Review Letters
|
September 22, 2023
Search for a Dark-Matter-Induced Cosmic Axion Background with ADMX
T Nitta, T Braine, N Du, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 674) with videos related to
Sort By:
Page
of 68
Disease Models & Mechanisms
|
October 11, 2019
Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice
Claudia Figueroa-Romero, Kai Guo, Benjamin J Murdock, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 14, 2018
OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9
Takenobu Ishii, Montserrat Ruiz-Torruella, Atsushi Ikeda, et al.
Clinical Endocrinology
|
December 20, 2021
Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society
Julie A Miller, Justin Gundara, Simon Harper, et al.
Clinical Endocrinology
|
December 21, 2021
Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society
Frances Milat, Sabashini K Ramchand, Madhuni Herath, et al.
European Urology Oncology
|
January 28, 2024
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)
Lih-Ming Wong, Tom Sutherland, Elisa Perry, et al.
Lancet (London, England)
|
March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.
European Urology Oncology
|
November 29, 2024
Baseline Nodal Status on <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
Michael S Hofman, Veeru Kasivisvanathan, Emma Link, et al.
Physical Review Letters
|
March 29, 2020
Extended Search for the Invisible Axion with the Axion Dark Matter Experiment
T Braine, R Cervantes, N Crisosto, et al.
Physical Review Letters
|
April 7, 2025
ADMX Axion Dark Matter Bounds around 3.3 μeV with Dine-Fischler-Srednicki-Zhitnitsky Discovery Ability
C Goodman, M Guzzetti, C Hanretty, et al.
Physical Review Letters
|
September 22, 2023
Search for a Dark-Matter-Induced Cosmic Axion Background with ADMX
T Nitta, T Braine, N Du, et al.
Page
of 68